National Institute of Allergy and Infectious Disease
COVID-19 Vaccines: Moderna declares successful trial results after Pfizer
The new vaccine candidate by Moderna Inc, called mRNA-1273, has reportedly shown 94.5% efficacy against the SARS-CoV-2 in the phase III clinical trials
- Children in Gaza charred to death as Israel strikes displaced people’s tents in designated “safe zone”
- Farmers in Pakistan mobilize to demand fair prices and agrarian reform
- Moroccan dockworkers call for boycott of Maersk’s arms shipment to Israel
- Trump’s immigration authorities arrest US citizen
- Health systems in Europe are running on overtime
